|
Volumn 37, Issue 10, 2012, Pages 556-558
|
Pharmaceutical approval update
|
Author keywords
[No Author keywords available]
|
Indexed keywords
DOCETAXEL;
EMTRICITABINE;
EMTRICITABINE PLUS TENOFOVIR DISOPROXIL;
ENZALUTAMIDE;
HUMAN IMMUNODEFICIENCY VIRUS PROTEINASE INHIBITOR;
NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR;
PLACEBO;
TENOFOVIR DISOPROXIL;
UNCLASSIFIED DRUG;
VINCRISTINE SULFATE;
XTANDI;
ACUTE LYMPHOBLASTIC LEUKEMIA;
ANTINEOPLASTIC ACTIVITY;
ANTIVIRAL ACTIVITY;
ANTIVIRAL THERAPY;
ANXIETY;
ARTHRALGIA;
ARTICLE;
ASTHENIA;
BACKACHE;
BONE MARROW SUPPRESSION;
CANCER SURVIVAL;
CASTRATION RESISTANT PROSTATE CANCER;
CAUDA EQUINA SYNDROME;
CONSTIPATION;
DIARRHEA;
DIZZINESS;
DRUG APPROVAL;
DRUG CONTRAINDICATION;
DRUG COST;
DRUG DOSE REGIMEN;
DRUG FATALITY;
DRUG INDICATION;
DRUG INDUCED HEADACHE;
DRUG SAFETY;
DRUG STRUCTURE;
DRUG WITHDRAWAL;
FATIGUE;
HEMATURIA;
HEPATITIS B;
HEPATOMEGALY;
HOT FLUSH;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
HYPERTENSION;
INJECTION SITE EXTRAVASATION;
INSOMNIA;
INTESTINE OBSTRUCTION;
LACTIC ACIDOSIS;
LIPOSOMAL DELIVERY;
LIVER TOXICITY;
LOWER RESPIRATORY TRACT INFECTION;
MIXED INFECTION;
MUSCLE WEAKNESS;
MUSCULOSKELETAL PAIN;
NEUROPATHY;
NEUROTOXICITY;
NONHODGKIN LYMPHOMA;
OVERALL SURVIVAL;
PARESTHESIA;
PERIPHERAL EDEMA;
PHILADELPHIA CHROMOSOME NEGATIVE CELL;
RECOMMENDED DRUG DOSE;
SEIZURE;
SIDE EFFECT;
SINGLE DRUG DOSE;
SPINAL CORD COMPRESSION;
STEATOSIS;
TABLET FORMULATION;
TERATOGENICITY;
TUMOR LYSIS SYNDROME;
UPPER RESPIRATORY TRACT INFECTION;
|
EID: 84867917940
PISSN: 10521372
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (10)
|
References (0)
|